Literature DB >> 7139961

Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria.

I Myara, C Charpentier, A Lemonnier.   

Abstract

Prolidase assay was reinvestigated by determining proline, using Chinard's method. Although several authors had previously tested this colorimetric reaction, accurate details regarding enzyme activity were not available. The need for greater sensitivity led to the introduction of several modifications: dialysis was eliminated and the substrate concentration and incubation time were changed. In addition, the reaction mixture was preincubated with Mn2+ for 24 h in order to triple prolidase activity. Color development followed at 90 degrees C, because of partial glycylproline hydrolysis at higher temperatures. The effect of several divalent cations on prolidase activity were tested with and without Mn2+. This modified assay was applied to erythrocytes, plasma and skin fibroblasts from a female patient with iminodipeptiduria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7139961     DOI: 10.1016/0009-8981(82)90196-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  68 in total

1.  Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells.

Authors:  Ewa Karna; Lukasz Szoka; Jerzy A Palka
Journal:  Mol Cell Biochem       Date:  2010-02-21       Impact factor: 3.396

2.  Identifying the structure of the active sites of human recombinant prolidase.

Authors:  Roberta Besio; Stefania Alleva; Antonella Forlino; Anna Lupi; Carlo Meneghini; Velia Minicozzi; Antonella Profumo; Francesco Stellato; Ruggero Tenni; Silvia Morante
Journal:  Eur Biophys J       Date:  2009-05-05       Impact factor: 1.733

3.  Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.

Authors:  H Korkmaz; S Tabur; M Ozkaya; E Oguz; N Aksoy; E Akarsu
Journal:  J Endocrinol Invest       Date:  2015-04-22       Impact factor: 4.256

4.  Expression and molecular analysis of mutations in prolidase deficiency.

Authors:  P Ledoux; C R Scriver; P Hechtman
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

5.  Enhanced prolidase activity and decreased collagen content in breast cancer tissue.

Authors:  Marzanna Cechowska-Pasko; Jerzy Pałka; Marek Z Wojtukiewicz
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

6.  Partial Rescue of Biochemical Parameters After Hematopoietic Stem Cell Transplantation in a Patient with Prolidase Deficiency Due to Two Novel PEPD Mutations.

Authors:  Désirée Caselli; Rolando Cimaz; Roberta Besio; Antonio Rossi; Ersilia De Lorenzi; Raffaella Colombo; Luca Cantarini; Silvia Riva; Marco Spada; Antonella Forlino; Maurizio Aricò
Journal:  JIMD Rep       Date:  2011-09-27

7.  Prolidase deficiency: biochemical classification of alleles.

Authors:  A P Boright; C R Scriver; G A Lancaster; F Choy
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

8.  Factor-Xa inhibitors protect against systemic oxidant damage induced by peripheral-ischemia reperfusion.

Authors:  Ahmet Caliskan; Celal Yavuz; Oguz Karahan; Suleyman Yazici; Orkut Guclu; Sinan Demirtas; Binali Mavitas
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

9.  Prolidase activity and oxidative status in patients with thalassemia major.

Authors:  Alpay Cakmak; Murat Soker; Ahmet Koc; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

10.  Serum prolidase activity and oxidative status in patients with bronchial asthma.

Authors:  Alpay Cakmak; Dost Zeyrek; Ali Atas; Hakim Celik; Nurten Aksoy; Ozcan Erel
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.